Assessment of Neuropsychiatric Adverse Events in Influenza Patients Treated with Oseltamivir: A Comprehensive Review

ISSN： 0114-5916

Source： Drug Safety, Vol.31, Iss.12, 2008-01, pp. : 1097-1114

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

ABCB1 polymorphisms and neuropsychiatric adverse events in oseltamivir-treated children during influenza H1N1/09 pandemia

By L’’Huillier Arnaud G Ing Lorenzini Kuntheavy Crisinel Pierre-Alex Rebsamen Michela C Fluss Joel Korff Christian M Barbe Remy P Siegrist Claire-Anne Dayer Pierre Posfay-Barbe Klara M Desmeules Jules A

Pharmacogenomics, Vol. 12, Iss. 10, 2011-10 ,pp. : 1493-1501

Future Medicine

Access to resources Recommend Favorite

Neuropsychiatric Adverse Events and Oseltamivir for Prophylaxis

By Jones Mark

Drug Safety, Vol. 35, Iss. 12, 2012-12 ,pp. : 1187-1188

Adis International

Access to resources Recommend Favorite

Oseltamivir: A Review of its Use in Influenza

By McClellan K. Perry C.M.

Drugs, Vol. 61, Iss. 2, 2001-01 ,pp. : 263-283

Adis International

Access to resources Recommend Favorite

Unexpected platelets elevation in a patient with idiopathic thrombocytopenia treated with oseltamivir for influenza infection

Fundamental & Clinical Pharmacology, Vol. 30, Iss. 5, 2016-10 ,pp. : 483-485

John Wiley & Sons Inc

Access to resources Recommend Favorite

Oseltamivir/peramivir: Development of oseltamivir and peramivir resistance in influenza A infection, in immunocompromised patients: 2 case reports

Reactions Weekly, Vol. 1, Iss. 1309, 2010-01 ,pp. : 31-31

Adis International

Access to resources Recommend Favorite